Cytokines and the blood-brain barrier

The Neuroimmunological Basis of Behavior and Mental Disorders

Volumn , Issue , 2009, Pages 3-17

  Banks, William A ^a   Lynch, Jessica L ^a   Price, Tulin O ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Brain; Cytokine; Immune cell; Interleukin; Tumor necrosis factor

Indexed keywords

EID: 78049258538     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-84851-8_1     Document Type: Chapter

References (78)

1. Abbas, KA, Lichtman, A, Prober, JS. Effector mechanisms of immune responses. 2000; In: Cellular and Molecular Immunology 4th Edition (Editors: KA Abbas, JS Prober) Saunders, Philadelphia. Abbott, NJ.
2. Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 2005; 25:5-23
3. Abbott, NJ, Ronnback, L, Hansson, E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev 2006; 7:41-53
4. Avison, MJ, Nath, A, Greene-Avison, R, Schmitt, FA, eenberg, RN, rgar, JR. Neuroimaging correlates of HIV-Associated BBB compromise. J Neuroimmunol 2004; 157:140-146
5. Banks, WA. Physiology and pathophysiology of the blood-brain barrier: Implications for microbial pathogenesis, drug delivery and neurodegenerative disorders. J Neurovirology 1999; 5:538-555
6. Banks, WA. Blood-brain barrier transport of cytokines: A mechanism for neuropathology. Curr Pharm Design 2005; 11:973-984
7. Banks, WA and Broadwell, RD. Blood to brain and brain to blood passage of native horseradish peroxidase, wheat germ agglutinin and albumin: pharmacokinetic and morphological assessments. J Neurochem 1994; 62:2404-2419
8. Banks, WA, Farr, SA, La Scola, ME, Morley, JE. Intravenous human interleukin-1 impairs memory processing in mice: Dependence on blood-brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther 2001; 299:536-541
9. Banks, WA and Kastin, AJ. Relative contributions of peripheral and central sources to levels of IL-1 in the cerebral cortex of mice: assessment with species-specific enzyme immunoassays. J Neuroimmunol 1997; 79:22-28
10. Banks, WA, Kastin, AJ, Akerstrom, V. HIV-1 protein gp120 crosses the blood-brain barrier: role of adsorptive endocytosis. Life Sci 1997; 61:L119-L125
11. Banks, WA, Kastin, AJ, Broadwell, RD. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 1995; 2:241-248
12. Banks, WA, Kastin, AJ, Gutierrez, EG. Penetration of interleukin-6 across the blood-brain barrier. Neurosci Lett 1994; 179:53-56
13. Banks, WA, Niehoff, ML, Zalcman, S. Permeability of the mouse blood-brain barrier to murine interleukin-2: Predominance of a saturable efflux system. Brain Behav Immun 2004; 18:434-442
14. Banks, WA, Ortiz, L, Plotkin, SR, Kastin, AJ. Human interleukin (IL) 1, murine IL-1 and murine IL-1 are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther 1991; 259:988-996
15. Basu, A, Krady, JK, Levison, SW. Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res 2004; 78:151-156
16. Begley, DJ. ABC transporters and the blood-brain barrier. Curr Pharm Design 2004; 10:1295-1312
17. Betz, AL and Goldstein, GW. Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries. Science 1978; 202:225-227
18. Blasberg, RG, Fenstermacher, JD, Patlak, CS. Transport of -Aminoisobutyric acid across brain capillary and cellular membranes. J Cereb Blood Flow Metab 1983; 3:8-32
19. Blesch, A, Uy, HS, Grill, RJ, Cheng, JG, Patterson, PH, Tuszynski, MH. Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury. J Neurosci 1999; 19:3356-3366
20. Bradbury, M. The Concept of a Blood-Brain Barrier. 1979; John Wiley and Sons LTD, New York
21. Chen, G, Castro, WL, Chow, HH, Reichlin, S. Clearance of 125I-labelled interleukin-6 from brain into blood following intracerebroventricular injection in rats. Endocrinology 1997; 138:4830-4836
22. Chen, G and Reichlin, S. Clearance of [125I]-tumor necrosis factor-from the brain into the blood after intracerebroventricular injection into rats. Neuroimmunomodulation 1998; 5:261-269
23. Chen, P, Shibata, M, Zidovetzki, R, Fisher, M, Zlokovic, BV, Hofman, FM. Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures. J Neuroimmunol 2001; 116:62-73
24. Christov, A, Ottman, JT, Grammas, P. Vascular inflammatory, oxidative and protease-based processes: implications for neuronal cell death in Alzheimers disease. Neurol Res 2004; 26:540-546
25. Davson, H and Segal, MB. Special aspects of the blood-brain barrier. 1996; 303-485
26. Di Gregorio, GB, Hensley, L, Lu, T, Ranganathan, G, Kern, PA. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol-Endoc Metab 2004; 287:E182-E187
27. Didier, N, Banks, WA, Creminon, C, Dereuddre-Bosquet, N, Mabondzo, A. HIV-1-induced production of endothelin-1 in an in vitro model of the human blood-brain barrier. Neuroreport 2002; 13:1179-1183
28. Dore-Duffy, P, Owen, C, Balabanov, R, Murphy, S, Beaumont, T, Rafols, JA. Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res 2000; 60:55-69
29. Fabry, Z, Fitzsimmons, KM, Herlein, JA, Moninger, TO, Dobbs, MB, Hart, MN. Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J Neuroimmunol 1993; 47:23-34
30. Frigerio, S, Gelati, M, Ciusani, E, Corsini, E, Dufour, A, Massa, G, Salmaggi, A. Immunocompetence of human microvascular brain endothelial cells: cytokine regulation of IL-1beta, MCP-1, IL-10, sICAM-1 and sVCAM-1. J Neurol 1998; 245:727-730
31. Grammas, P and Ovase, R. Inflammatory factors are elevated in brain microvessels in Alzheimers disease. Neurobiol Aging 2001; 22:837-842
32. Gutierrez, EG, Banks, WA, Kastin, AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993; 47:169-176
33. Hofman, F, Chen, P, Incardona, F, Zidovetzki, R, Hinton, DR. HIV-tat protein induces the production of interleukin-8 by human brain-derived endothelial cells. J Neuroimmunol 1999; 94:28-39
34. Kastin, AJ, Akerstrom, V, Pan, W. Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier: meaningful controls. Peptides 2001; 22:2127-2136
35. Koistinaho, M and Koistinahi, J. Interactions between Alzheimers disease and cerebral ischemia-focus on inflammation. Brain Res Brain Res Rev 2005; 48:240-250
36. Lai, CH and Kuo, KH. The critical component to establish in vitro BBB model: pericyte. Brain Res Rev 2005; 50:258-265
37. Lampl, Y, Fleminger, G, Gilad, R, Galron, R, Sarova-Pinhas, I, Sokolovsky, M. Endothelin in cerebrospinal fluid and plasma of patients in the early stages of ischemic stroke. Stroke 1997; 28:1951-1955
38. Larson, SJ and Dunn, AJ. Behavioral effects of cytokines. Brain Behav Immun 2001; 15:371-387
39. Lee, G, Dallas, S, Hong, M, Bendayan, R. Drug transporters in the central nervous system: brain barriers and brain paranchyma considerations. Pharmacol Rev 2001; 53:569-596
40. Lee, YW, Hennig, B, Fiala, M, Kim, KS, Toborek, M. Cocaine activates redox-regulated transcription factors and induces TNF-Alpha expression in human brain endothelial cells. Brain Res 2001; 920:125-133
41. Liao, YF, Wang, BJ, Cheng, HT, Kuo, LH, Wolfe, MS. Tumor necrosis factor-Alpha, interleukin-1-beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem 2004; 279:49523-49532
42. Lynch, JL and Banks, WA. Opiate modulation of IL-1alpha, IL-2, and TNF-Alpha transport across the blood-brain barrier. Brain Behav Immun 2008 Oct; 22(7):1096-102
43. Maness, LM, Banks, WA, Zadina, JE, Kastin, AJ. Selective transport of blood-borne interleukin-1 into the posterior division of the septum of the mouse brain. Brain Res 1995; 700:83-88
44. Moinuddin, A, Morley, JE, Banks, WA. Regional variations in the transport of interleukin-1 across the blood-brain barrier in ICR and aging SAMP8 mice. Neuroimmunomodulation 2000; 8:165-170
45. Pan, W, Banks, WA, Kastin, AJ. BBB permeability to ebiratide and TNF in acute spinal cord injury. Exp Neurol 1997; 146:367-373
46. Pan, W, Banks, WA, Kastin, AJ. Permeability of the blood-brain barrier and blood-spinal cord barriers to interferons. J Neuroimmunol 1997; 76:105-111
47. Pan, W, Banks, WA, Kennedy, MK, Gutierrez, EG, Kastin, AJ. Differential permeability of the BBB in acute EAE: enhanced transport of TNF-. Am J Physiol 1996; 271:E636-E642
48. Pan, W, Cain, C, Yu, Y, Kastin, AJ. Receptor-mediated transport of LIF across the blood-spinal barrier is upregulated after spinal cord injury. J Neuroimmunol 2006; 174:119-125
49. Pan, W and Kastin, AJ. Increase in TNF alpha transport after SCI is specific for time, region, and type of lesion. Exp Neurol 2001; 170:357-363
50. Pan, W, Kastin, AJ, Brennan, JM. Saturable entry of leukemia inhibitory factor from blood to the central nervous system. J Neuroimmunol 2000; 106:172-180
51. Pardridge, WM. Molecular biology of the blood-brain barrier. Mol Biotechnol 2005; 30:57-70
52. Patlak, CS, Blasberg, RG, Fenstermacher, JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3:1-7
53. Persidsky, Y, Ramirez, SH, Haorah, J, Kanmogne, GD. Blood-brain barrier: Structural components and function under physiologic and pathologic conditions. Neuroimmune Pharmacol 2006; 1:223-236
54. Qi, Y, Takahashi, N, Hileman, SM, Patel, HR, Berg, AH, Pajvani, UB, Scherer, PE, Ahima, S. Adiponectin acts in the brain to decrease body weight. Nature Medicine 2004; 10:524-529
55. Qin, Y and Sato, TN. Mouse multidrug resistance 1a/3 gene is the earliest known endothelial cell differentiation marker during blood-brain barrier development. Dev Dynamics 1995; 202: 172-180
56. Quan, N and Banks, WA. Brain-immune communication pathways. Brain Behav Immun 2007; 21:727-735
57. Rapoport, SI. Blood Brain Barrier in Physiology and Medicine. 1976; Raven Press, New York.
58. Reese, TS and Karnovsky, MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 1967; 34:207-217
59. Reyes, TM, Fabry, Z, Coe, CL. Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli. Brain Res 1999; 851:215-220
60. Rolinski, B, Heigermoser, A, Lederer, E, Bogner, JR, Loch, O, Goebel, FD. Endothelin-1 elevated in the cerebrospinal fluid of HIV-infected patients with encephalopathy. Infection 1999; 27:244-247
61. Roy, S, Balasubrmanian, S, Sumandeep, S, Charboneau, R, Wang, J, Melnyk, D, Beilman, GJ, Vatassery, R, Barke, RA. Morphine directs T cells towards T(H2) differentiation. Surgery 2001; 130:304-309
62. Roy, S, Loh, HH, Barke, RA. Morphine-induced suppression of thymocyte proliferation is mediated by inhibition of IL-2 synthesis. Adv Exp Med Biol 1995; 373:41-48
63. Spector, R and Johanson, CE. The mammalian choroid plexus. Sci Am 1989; 261:68-74
64. Spranger, J, Verma, S, Gohring, I, Bobbert, T, Seifert, J, Sindler, AL, Pfeiffer, A, Hileman, SM, Tschop, M, Banks, WA. Adiponectin does not cross the blood-brain barrier, but modifies cytokine expression of brain endothelial cells. Diabetes 2006; 55:141-147
65. Stenlof, K, Wernstedt, I, Fjallman, T, Wallenius, V, Wallenius, K, Jansson, JO. Internleukin-6 levels in the central nervous system are negatively correlated with fat mass in overwieght/ obese subjects. J Clin Endocrinol Metab 2003; 88:4379-4383
66. Stins, MF, Shen, Y, Huang, SH, Gilles, F, Kalra, VK, Kim, KS. Gp120 activates childrens brain endothelial cells via CD4. J Neurovirol 2001; 7:125-134
67. Suzuki, H, Sato, S, Suzuki, Y, Takekoshi, K, Ishihara, N, Shimoda, S. Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol Scand 1990; 81:553-554
68. Taylor, EM. The impact of efflux transporters in the brain on the development of drugs for CNS disorders. Clin Pharmacokinet 2002; 41:81-92
69. Vadeboncoeur, N, Segura, M, Al-Numani, D, Vanier, G, Gottschalk, M. Proinflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol Med Mic 2003; 35:49-58
70. Verma, S, Nakaoke, R, Dohgu, S, Banks, WA. Release of cytokines by brain endothelial cells: a polarized response to lipopolysaccharide. Brain Behav Immun 2006; 20:449-455
71. Vilcek, J. The cytokines: an overview. 2003; The Cytokine Handbook, 4th Edition Editor MT Thompson, Elsevier, Amsterdam.
72. Waguespack, PJ, Banks, WA, Kastin, AJ. Interleukin-2 does not cross the blood-brain barrier by a saturable transport system. Brain Res Bull 1994; 34:103-109
73. Wallenius, V, Wallenius, K, Ahren, B, Rudling, M, Carlsten, H, Dickson, SL, Ohlsson, C, Jansson, JO. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002; 8:75-79
74. Walz, W. Role of astrocytes in the clearance of excess extracellular potassium. Neurochem Int 2000; 36:291-300
75. Xiang, S, Pan, W, Kastin, AJ. Strategies to create a regenerating environment for the injured spinal cord. Curr Pharm Design 2005; 11:1267-1277
76. Yanagisawa, M, Kurihara, H, Kimura, S, Tomobe, Y, Kobayashi, M, Mitsui, Y, Yazaki, Y, Goto, K, Masaki, T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415
77. Zhao, Y, Cui, JG, Lukiw, WJ. Natural secretory products of human neural and microvessel endothelial cells: implications in pathogenic spreading and Alzheimers disease. Mol Neurobiol 2006; 34:181-192
78. Zlokovic, BV. Neurovascular mechanisms of Alzheimers neurodegeneration. Trends Neurosci 2005; 28:202-208.